Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well‐characterized cohorts
Abstract
Our objective was to investigate the effect of sex on cognitive decline within the context of amyloid β (Aβ) burden and apolipoprotein E genotype.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 24, 2018
- Source ID
- 10.1016/j.jalz.2018.04.010
Entities
People
- Aaron P. Schultz
- Annette Dobson
- Bernard J Hanseeuw
- Christopher C Rowe
- Colin L. Masters
- Dorene M. Rentz
- Dylan Kirn
- Elizabeth C. Mormino
- Heidi I.l. Jacobs
- Jasmeer Chhatwal
- Jennifer S. Rabin
- Kathryn V. Papp
- Keith A. Johnson
- Michael C. Donohue
- Michael J. Properzi
- Michael Waller
- On Behalf Of Collaborators In The Alzheimer's Disease Neuroimaging Initiative
- Paul Maruff
- Rachel F Buckley
- Rebecca E. Amariglio
- Reisa A. Sperling
- Samantha Burnham
- The Australian Imaging, Biomarker And Lifestyle Study Of Ageing
- The Harvard Aging Brain Study
- Trey Hedden
- Victor L. Villemagne
- Vincent Doré
- Yen Ying Lim
Organizations
- Alzheimer Netherlands
- Alzheimer's Association
- Commonwealth Scientific and Industrial Research Organisation
- Eli Lilly and Company
- Fidelity Biosciences (United States)
- Harvard Medical School
- Harvard NeuroDiscovery Center
- Maastricht University
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- Stanford University
- UCLouvain
- United States Department of Defense
- University of Melbourne
- University of Queensland
- University of Southern California